Browse Data and Analysis

This report described Burma’s current production, regulations and trade for genetically engineered products, as well as recent activities focused on agricultural biotechnology. Burma’s (also called Myanmar) National Biosafety Framework and Biosafety Guidelines have been pending approval by the Ministry of Agriculture since before the 2021 coup.

Singapore does not have any domestic commercial production of plant biotechnology. The Singapore Food Agency (SFA) website lists 108 genetically engineered (GE) crops approved for use as food for direct consumption, ingredients, and further processing into ingredients for other food in the country.

This report describes the status of Burma’s production and regulations for genetically engineered products and recent activities focused on agricultural biotechnology.

Singapore does not have any domestic commercial production of plant biotechnology. The Singapore Food Agency website lists 106 genetically engineered (GE) crops approved for use as food for direct consumption, ingredients, and further processing into ingredients for other food in the country.

Singapore does not have any domestic commercial production of plant biotechnology. The Singapore Food Agency provides a link in its website that lists a total of 64 genetically engineered (GE) crops that have been approved for use as food for direct consumption, ingredients, and further processing into ingredients for other food in the country.

This report describes the status of Burma’s production, regulations, public attitudes, trading, and labeling requirements for genetic engineered products and the current activities for agricultural biotechnology.

Singapore does not have any domestic commercial production of plant biotechnology. The Singapore Food Agency provides a link in its website that lists a total of 57 genetically engineered (GE) crops that have been approved for use as food for direct consumption, ingredients, and further processing into ingredients for other food in the country.

There are no significant developments to convey since the previous report from October 2020. Although Burma (also called Myanmar) does not yet have a comprehensive biosafety legislation, the final version of the National Biosafety Framework and Biosafety Guidelines are completed and pending approval.

Singapore does not have any domestic commercial production of plant biotechnology.

Although Burma (also called Myanmar) does not yet have a comprehensive biosafety legislation, the final version of the National Biosafety Framework is completed and pending approval...

There are no significant developments to convey since the previous report from November 2018.

Singapore does not have any domestic commercial production of plant biotechnology.